For example, Apo-2L/TRAIL-mimetic peptides mimic the TRAIL ligand and bind specifically to TRAIL R2 (DR5), inducing selective apoptosis in cancer cells without affecting normal cells [139]. Here, TNFSF10 is linked to cancer.